deflazacort
Drug Details
- Generic Name
- deflazacort
- Brand Names
- EMFLAZA, DEFLAZACORT, PYQUVI, Deflazacort
- Application Number
- NDA208684
- Sponsor
- PTC Therapeutics, Inc.
- NDC Codes
- 10
- Dosage Forms
- TABLET, SUSPENSION
- Routes
- ORAL
- Active Ingredients
- DEFLAZACORT
Indications and Usage
1 INDICATIONS AND USAGE JAYTHARI is indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 5 years of age and older. Additional pediatric use information is approved for PTC Therapeutics, Inc.'s Emflaza™ (deflazacort) tablets. However, due to PTC Therapeutics, Inc.'s marketing exclusivity rights, this drug product is not labeled with that information. JAYTHARI is a corticosteroid indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 5 years of age and older ( 1 )